Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...
The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from ...
MPM Medical today announced a major expansion of its U.S. manufacturing capabilities with the acquisition of a full collagen manufacturing platform and the associated FDA 510 (k) clearance for ...
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, a trailblazer in advanced label-free cellular bioanalytical technology and instrumentation, proudly announces the launch of the Laser Force Cytology™ ...
WHITE OAK, Md.--(BUSINESS WIRE)--The Food and Drug Administration’s (FDA) Office of Counterterrorism and Emerging Threats (OCET) has awarded a contract worth over $1.78M to Siemens Government ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback